339 related articles for article (PubMed ID: 26767494)
41. Anaphylaxis with clonal mast cells in normal looking skin - a new entity?
Bretterklieber A; Beham-Schmid C; Sturm GJ; Berghold A; Brezinschek R; Aberer W; Aberer E
Allergy; 2015 Jul; 70(7):864-72. PubMed ID: 25899109
[TBL] [Abstract][Full Text] [Related]
42. Patients with mast cell activation symptoms and elevated baseline serum tryptase level have unique bone marrow morphology.
Giannetti MP; Akin C; Hufdhi R; Hamilton MJ; Weller E; van Anrooij B; Lyons JJ; Hornick JL; Pinkus G; Castells M; Pozdnyakova O
J Allergy Clin Immunol; 2021 Apr; 147(4):1497-1501.e1. PubMed ID: 33248113
[TBL] [Abstract][Full Text] [Related]
43. Systemic mastocytosis in adults: 2015 update on diagnosis, risk stratification, and management.
Pardanani A
Am J Hematol; 2015 Mar; 90(3):250-62. PubMed ID: 25688753
[TBL] [Abstract][Full Text] [Related]
44. Bone mineral density, bone turnover markers and fractures in patients with indolent systemic mastocytosis.
Rossini M; Zanotti R; Bonadonna P; Artuso A; Caruso B; Schena D; Vecchiato D; Bonifacio M; Viapiana O; Gatti D; Senna G; Riccio A; Passalacqua G; Pizzolo G; Adami S
Bone; 2011 Oct; 49(4):880-5. PubMed ID: 21782049
[TBL] [Abstract][Full Text] [Related]
45. The impact of sensitive KIT D816V detection on recognition of indolent Systemic Mastocytosis.
De Matteis G; Zanotti R; Colarossi S; De Benedittis C; Garcia-Montero A; Bonifacio M; Sartori M; Aprili F; Caruso B; Paviati E; Carli G; Perbellini O; Zamò A; Bonadonna P; Pizzolo G; Guidi G; Martinelli G; Soverini S
Leuk Res; 2015 Mar; 39(3):273-8. PubMed ID: 25582384
[TBL] [Abstract][Full Text] [Related]
46. Systemic mastocytosis: A cohort study on clinical characteristics of 136 patients in a large tertiary centre.
Hermans MAW; Rietveld MJA; van Laar JAM; Dalm VASH; Verburg M; Pasmans SGMA; Gerth van Wijk R; van Hagen PM; van Daele PLA
Eur J Intern Med; 2016 May; 30():25-30. PubMed ID: 26809706
[TBL] [Abstract][Full Text] [Related]
47. Clonal mast cell proliferation in pruriginous skin in hypereosinophilic syndrome.
Wiednig M; Beham-Schmid C; Kranzelbinder B; Aberer E
Dermatology; 2013; 227(1):67-71. PubMed ID: 24008407
[TBL] [Abstract][Full Text] [Related]
48. [Vulvar oedema revealing systemic mastocytosis].
Deveza E; Locatelli F; Girardin M; Valmary-Degano S; Daguindau E; Aubin F; Humbert P; Pelletier F
Ann Dermatol Venereol; 2015 Nov; 142(11):685-9. PubMed ID: 26003033
[TBL] [Abstract][Full Text] [Related]
49. Diagnostic value of immunostaining for tryptase in patients with mastocytosis.
Horny HP; Sillaber C; Menke D; Kaiserling E; Wehrmann M; Stehberger B; Chott A; Lechner K; Lennert K; Valent P
Am J Surg Pathol; 1998 Sep; 22(9):1132-40. PubMed ID: 9737247
[TBL] [Abstract][Full Text] [Related]
50. Myelomastocytic leukemia: histopathological features, diagnostic criteria and differential diagnosis.
Horny HP; Sotlar K; Reiter A; Valent P
Expert Rev Hematol; 2014 Aug; 7(4):431-7. PubMed ID: 25025369
[TBL] [Abstract][Full Text] [Related]
51. [Systemic mastocytosis: a heterogeneous disease].
Hermans MA; Verburg M; van Laar JA; van Hagen PM; Pasmans SG; van Daele PL
Ned Tijdschr Geneeskd; 2016; 160():A9340. PubMed ID: 27229688
[TBL] [Abstract][Full Text] [Related]
52. Can Diagnostic Low-dose Whole-body CT Reflect Bone Marrow Findings in Systemic Mastocytosis?
Meyer HJ; Pönisch W; Monecke A; Gundermann P; Surov A
Anticancer Res; 2020 Feb; 40(2):1015-1022. PubMed ID: 32014947
[TBL] [Abstract][Full Text] [Related]
53. Mast cell activation syndrome: improved identification by combined determinations of serum tryptase and 24-hour urine 11β-prostaglandin2α.
Ravi A; Butterfield J; Weiler CR
J Allergy Clin Immunol Pract; 2014; 2(6):775-8. PubMed ID: 25439370
[TBL] [Abstract][Full Text] [Related]
54. Differential diagnoses of systemic mastocytosis in routinely processed bone marrow biopsy specimens: a review.
Horny HP; Sotlar K; Valent P
Pathobiology; 2010; 77(4):169-80. PubMed ID: 20616612
[TBL] [Abstract][Full Text] [Related]
55. Systemic mastocytosis presenting with a prominent B lymphocyte proliferation in the bone marrow and extensive fibrosis of the spleen.
Neşe N; Cagirgan S; Ertan Y; Sönmez A; Soydan S; Hekimgil M
Dis Markers; 2007; 23(3):167-71. PubMed ID: 17473386
[TBL] [Abstract][Full Text] [Related]
56. Clonal mast cell disorders in patients with severe Hymenoptera venom allergy and normal serum tryptase levels.
Zanotti R; Lombardo C; Passalacqua G; Caimmi C; Bonifacio M; De Matteis G; Perbellini O; Rossini M; Schena D; Busa M; Marcotulli MC; Bilò MB; Franchini M; Marchi G; Simioni L; Bonadonna P
J Allergy Clin Immunol; 2015 Jul; 136(1):135-9. PubMed ID: 25605272
[TBL] [Abstract][Full Text] [Related]
57. The Italian Mastocytosis Registry: 6-year experience from a hospital-based registry.
Merante S; Ferretti VV; Elena C; Brazzelli V; Zanotti R; Neri I; Magliacane D; Belloni Fortina A; Ingeborg F; Pastorello EA; Pieri L; Papayannidis C; Mauro M; Grifoni F; Minelli R; Guggiari E; Difonzo E; Bocchia M; Caroppo F; Di Nuzzo S; Elli EM; Rondoni M; Ciccocioppo R; Di Stefano M; Bossi G; Boveri E; Bonadonna P; Giona F; Valent P; Triggiani M
Future Oncol; 2018 Nov; 14(26):2713-2723. PubMed ID: 30207489
[TBL] [Abstract][Full Text] [Related]
58. Highly sensitive assays are mandatory for the differential diagnosis of patients presenting with symptoms of mast cell activation: diagnostic work-up of 38 patients.
Van den Poel B; Kochuyt AM; Del Biondo E; Dewaele B; Lierman E; Tousseyn T; de Hertogh G; Vandenberghe P; Boeckx N
Acta Clin Belg; 2017 Apr; 72(2):123-129. PubMed ID: 28262030
[TBL] [Abstract][Full Text] [Related]
59. The potential clinical utility of serum alpha-protryptase levels.
Kanthawatana S; Carias K; Arnaout R; Hu J; Irani AM; Schwartz LB
J Allergy Clin Immunol; 1999 Jun; 103(6):1092-9. PubMed ID: 10359891
[TBL] [Abstract][Full Text] [Related]
60. High-sensitivity flow cytometric analysis for the evaluation of systemic mastocytosis including the identification of a new flow cytometric criterion for bone marrow involvement.
Pozdnyakova O; Kondtratiev S; Li B; Charest K; Dorfman DM
Am J Clin Pathol; 2012 Sep; 138(3):416-24. PubMed ID: 22912359
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]